Global Pet Pharmaceuticals Market Growth 2024-2030

Publication ID:

LPI01243160

Publication Date:

January 4, 2024

Pages:

112

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Pet Pharmaceuticals market size was valued at US$ 13960 million in 2023. With growing demand in downstream market, the Pet Pharmaceuticals is forecast to a readjusted size of US$ 22800 million by 2030 with a CAGR of 7.3% during review period.
The research report highlights the growth potential of the global Pet Pharmaceuticals market. Pet Pharmaceuticals are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Pet Pharmaceuticals. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Pet Pharmaceuticals market.
Pet pharmaceutical refers specifically to medicines given to pets.
In terms of the purpose of use, pet drugs are mainly used by dogs and cats. Through drug prevention and treatment of pet diseases, the cure rate of pet diseases can be improved, the physical and mental health of pets can be guaranteed, and the quality of life of pets can be improved.
In terms of clinical significance, the application of pet drugs can provide clinical data for the research and development of new pet drugs, and promote the replacement and upgrading of new pet drugs.
The major players in global Pet Pharmaceuticals market include Zoetis, Boehringer Ingelheim, Merck, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Antiparasitic is the main type, with a share about 30%. Prevention is the main application, which holds a share about 80%.
Key Features:
The report on Pet Pharmaceuticals market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Pet Pharmaceuticals market. It may include historical data, market segmentation by Type (e.g., Antiparasitic, Biological Products), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Pet Pharmaceuticals market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Pet Pharmaceuticals market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Pet Pharmaceuticals industry. This include advancements in Pet Pharmaceuticals technology, Pet Pharmaceuticals new entrants, Pet Pharmaceuticals new investment, and other innovations that are shaping the future of Pet Pharmaceuticals.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Pet Pharmaceuticals market. It includes factors influencing customer ' purchasing decisions, preferences for Pet Pharmaceuticals product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Pet Pharmaceuticals market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Pet Pharmaceuticals market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Pet Pharmaceuticals market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Pet Pharmaceuticals industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Pet Pharmaceuticals market.
Market Segmentation:
Pet Pharmaceuticals market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Antiparasitic
Biological Products
Antibacterial
Others
Segmentation by application
Prevention
Treatment
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Chopperlvya Animal Health
CAHIC
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pet Pharmaceuticals market?
What factors are driving Pet Pharmaceuticals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pet Pharmaceuticals market opportunities vary by end market size?
How does Pet Pharmaceuticals break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pet Pharmaceuticals Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Pet Pharmaceuticals by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Pet Pharmaceuticals by Country/Region, 2019, 2023 & 2030
2.2 Pet Pharmaceuticals Segment by Type
2.2.1 Antiparasitic
2.2.2 Biological Products
2.2.3 Antibacterial
2.2.4 Others
2.3 Pet Pharmaceuticals Sales by Type
2.3.1 Global Pet Pharmaceuticals Sales Market Share by Type (2019-2024)
2.3.2 Global Pet Pharmaceuticals Revenue and Market Share by Type (2019-2024)
2.3.3 Global Pet Pharmaceuticals Sale Price by Type (2019-2024)
2.4 Pet Pharmaceuticals Segment by Application
2.4.1 Prevention
2.4.2 Treatment
2.5 Pet Pharmaceuticals Sales by Application
2.5.1 Global Pet Pharmaceuticals Sale Market Share by Application (2019-2024)
2.5.2 Global Pet Pharmaceuticals Revenue and Market Share by Application (2019-2024)
2.5.3 Global Pet Pharmaceuticals Sale Price by Application (2019-2024)
3 Global Pet Pharmaceuticals by Company
3.1 Global Pet Pharmaceuticals Breakdown Data by Company
3.1.1 Global Pet Pharmaceuticals Annual Sales by Company (2019-2024)
3.1.2 Global Pet Pharmaceuticals Sales Market Share by Company (2019-2024)
3.2 Global Pet Pharmaceuticals Annual Revenue by Company (2019-2024)
3.2.1 Global Pet Pharmaceuticals Revenue by Company (2019-2024)
3.2.2 Global Pet Pharmaceuticals Revenue Market Share by Company (2019-2024)
3.3 Global Pet Pharmaceuticals Sale Price by Company
3.4 Key Manufacturers Pet Pharmaceuticals Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet Pharmaceuticals Product Location Distribution
3.4.2 Players Pet Pharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pet Pharmaceuticals by Geographic Region
4.1 World Historic Pet Pharmaceuticals Market Size by Geographic Region (2019-2024)
4.1.1 Global Pet Pharmaceuticals Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Pet Pharmaceuticals Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Pet Pharmaceuticals Market Size by Country/Region (2019-2024)
4.2.1 Global Pet Pharmaceuticals Annual Sales by Country/Region (2019-2024)
4.2.2 Global Pet Pharmaceuticals Annual Revenue by Country/Region (2019-2024)
4.3 Americas Pet Pharmaceuticals Sales Growth
4.4 APAC Pet Pharmaceuticals Sales Growth
4.5 Europe Pet Pharmaceuticals Sales Growth
4.6 Middle East & Africa Pet Pharmaceuticals Sales Growth
5 Americas
5.1 Americas Pet Pharmaceuticals Sales by Country
5.1.1 Americas Pet Pharmaceuticals Sales by Country (2019-2024)
5.1.2 Americas Pet Pharmaceuticals Revenue by Country (2019-2024)
5.2 Americas Pet Pharmaceuticals Sales by Type
5.3 Americas Pet Pharmaceuticals Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Pharmaceuticals Sales by Region
6.1.1 APAC Pet Pharmaceuticals Sales by Region (2019-2024)
6.1.2 APAC Pet Pharmaceuticals Revenue by Region (2019-2024)
6.2 APAC Pet Pharmaceuticals Sales by Type
6.3 APAC Pet Pharmaceuticals Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pet Pharmaceuticals by Country
7.1.1 Europe Pet Pharmaceuticals Sales by Country (2019-2024)
7.1.2 Europe Pet Pharmaceuticals Revenue by Country (2019-2024)
7.2 Europe Pet Pharmaceuticals Sales by Type
7.3 Europe Pet Pharmaceuticals Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pet Pharmaceuticals by Country
8.1.1 Middle East & Africa Pet Pharmaceuticals Sales by Country (2019-2024)
8.1.2 Middle East & Africa Pet Pharmaceuticals Revenue by Country (2019-2024)
8.2 Middle East & Africa Pet Pharmaceuticals Sales by Type
8.3 Middle East & Africa Pet Pharmaceuticals Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet Pharmaceuticals
10.3 Manufacturing Process Analysis of Pet Pharmaceuticals
10.4 Industry Chain Structure of Pet Pharmaceuticals
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet Pharmaceuticals Distributors
11.3 Pet Pharmaceuticals Customer
12 World Forecast Review for Pet Pharmaceuticals by Geographic Region
12.1 Global Pet Pharmaceuticals Market Size Forecast by Region
12.1.1 Global Pet Pharmaceuticals Forecast by Region (2025-2030)
12.1.2 Global Pet Pharmaceuticals Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pet Pharmaceuticals Forecast by Type
12.7 Global Pet Pharmaceuticals Forecast by Application
13 Key Players Analysis
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Pet Pharmaceuticals Product Portfolios and Specifications
13.1.3 Zoetis Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim Pet Pharmaceuticals Product Portfolios and Specifications
13.2.3 Boehringer Ingelheim Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Pet Pharmaceuticals Product Portfolios and Specifications
13.3.3 Merck Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Elanco
13.4.1 Elanco Company Information
13.4.2 Elanco Pet Pharmaceuticals Product Portfolios and Specifications
13.4.3 Elanco Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Elanco Main Business Overview
13.4.5 Elanco Latest Developments
13.5 Virbac
13.5.1 Virbac Company Information
13.5.2 Virbac Pet Pharmaceuticals Product Portfolios and Specifications
13.5.3 Virbac Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Virbac Main Business Overview
13.5.5 Virbac Latest Developments
13.6 Dechra Veterinary Products
13.6.1 Dechra Veterinary Products Company Information
13.6.2 Dechra Veterinary Products Pet Pharmaceuticals Product Portfolios and Specifications
13.6.3 Dechra Veterinary Products Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Dechra Veterinary Products Main Business Overview
13.6.5 Dechra Veterinary Products Latest Developments
13.7 Ceva
13.7.1 Ceva Company Information
13.7.2 Ceva Pet Pharmaceuticals Product Portfolios and Specifications
13.7.3 Ceva Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Ceva Main Business Overview
13.7.5 Ceva Latest Developments
13.8 Vetoquinol
13.8.1 Vetoquinol Company Information
13.8.2 Vetoquinol Pet Pharmaceuticals Product Portfolios and Specifications
13.8.3 Vetoquinol Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Vetoquinol Main Business Overview
13.8.5 Vetoquinol Latest Developments
13.9 Ouro Fino Saude
13.9.1 Ouro Fino Saude Company Information
13.9.2 Ouro Fino Saude Pet Pharmaceuticals Product Portfolios and Specifications
13.9.3 Ouro Fino Saude Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Ouro Fino Saude Main Business Overview
13.9.5 Ouro Fino Saude Latest Developments
13.10 Norbrook
13.10.1 Norbrook Company Information
13.10.2 Norbrook Pet Pharmaceuticals Product Portfolios and Specifications
13.10.3 Norbrook Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Norbrook Main Business Overview
13.10.5 Norbrook Latest Developments
13.11 Jindun
13.11.1 Jindun Company Information
13.11.2 Jindun Pet Pharmaceuticals Product Portfolios and Specifications
13.11.3 Jindun Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Jindun Main Business Overview
13.11.5 Jindun Latest Developments
13.12 Chopperlvya Animal Health
13.12.1 Chopperlvya Animal Health Company Information
13.12.2 Chopperlvya Animal Health Pet Pharmaceuticals Product Portfolios and Specifications
13.12.3 Chopperlvya Animal Health Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Chopperlvya Animal Health Main Business Overview
13.12.5 Chopperlvya Animal Health Latest Developments
13.13 CAHIC
13.13.1 CAHIC Company Information
13.13.2 CAHIC Pet Pharmaceuticals Product Portfolios and Specifications
13.13.3 CAHIC Pet Pharmaceuticals Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 CAHIC Main Business Overview
13.13.5 CAHIC Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂